A. Pfaltz and A. Franzke
nigan MAT LCQ spectrometers (ESI). Elemental analyses were per-
formed by the staff of the Micro Analysis Laboratory at the University
of Basel. IR spectra were measured on a Perkin–Elmer 1600 FTIR spec-
trometer. Melting points were determined on a Bꢃchi 535 apparatus and
are uncorrected. Specific rotations were measured on a Perkin–Elmer
314 polarimeter. HPLC analyses were performed on a Shimadzu system,
GC measurements on equipment from Carlo Erba Instruments. The ab-
trated under reduced pressure. Purification of the crude product by
column chromatography under argon (silica gel, 4ꢄ23 cm; CH2Cl2) gave
precatalyst 43a as a red solid (253 mg, 82%). RF =0.65 (CH2Cl2, tailing);
[a]2D0 =+209 (c=0.230 in CHCl3); 1H NMR (500.1 MHz, CDCl3, 295 K):
d=1.05 (mc, 1H; CH(N)CH2CHH), 1.17–1.47 (m, 4H; CH(N)CHHCHH
and COD-CHH), 1.56 (mc, 1H; COD-CHH), 1.70 (d, J=11.4 Hz, 1H;
CH(N)CHH), 1.77 (d, J=13.7 Hz, 1H; CH(N)CH2CHH), 1.87 (d, J=
12.9 Hz, 1H; CH(N)CH2CHH), 1.90–2.04 (m, 3H; COD-CHH and Im-
7a-H), 2.21–2.48 (m, 4H; COD-CH2), 2.65 (d, J=11.1 Hz, 1H;
CH(N)CHH), 3.09 (mc, 1H; COD-CH), 3.30 (t, J=12.6 Hz, 1H; Im-3a-
H), 3.88 (d, J=15.5 Hz, 1H; Bn-CHH), 3.93 (brs, 1H; COD-CH), 4.46
(d, J=15.6 Hz, 1H; Bn-CHH), 4.52 (quint, J=7.1 Hz, 1H; COD-CH),
5.35 (brs, 1H; COD-CH), 7.13 (dd, J=10.7, 7.3 Hz, 2H; PPh2-o-H),
7.44–7.68 (m, 11H; Ar-H), 7.70 ppm (dd, J=7.5, 3.4 Hz, 1H; Ar-6’’-H);
13C{1H} NMR (125.8 MHz, CDCl3, 295 K): d=24.3 (CH(N)CH2CH2),
25.1 (CH(N)CH2CH2), 25.7 (COD-CH2), 28.1 (COD-CH2), 29.9
(CH(N)CH2), 33.8 (CH(N)CH2), 34.6 (COD-CH2), 37.2 (d, J=5 Hz;
COD-CH2), 41.6 (Bn-CH2), 63.0 (COD-CH), 65.7 (COD-CH), 70.2 (Im-
3a-CH), 72.4 (Im-7a-CH), 86.0 (d, J=16 Hz; COD-CH), 95.7 (d, J=
9 Hz; COD-CH), 108.4 (t, J=19 Hz; Bn-i-C), 121.5 (d, J=52 Hz; PPh2-i-
C), 124.1 (br; C6F5-i-C), 125.6 (d, J=49 Hz; Ar-2’-C), 129.2 (d, J=10 Hz;
Ar-CH), 129.5 (d, J=52 Hz; PPh2-i-C), 129.5 (d, J=11 Hz; Ar-CH),
130.0 (brd, J=7 Hz; Ar-6’-CH), 131.2 (Ar-CH), 132.2–132.3 (several Ar-
CH and Ar-1’-C), 132.7 (d, J=7 Hz; Ar-CH), 132.8 (d, J=2 Hz; Ar-CH),
133.7 (d, J=10 Hz; PPh2-o-CH), 136.3 (dmc, J=244 Hz; C6F5-m-C), 137.7
(dmc, J=253 Hz; Bn-m-C), 138.3 (dmc, J=244 Hz; C6F5-p-C), 141.7 (dmc,
J=257 Hz; Bn-p-C), 145.3 (dmc, J=250 Hz; Bn-o-C), 148.3 (dmc, J=
241 Hz; C6F5-o-C), 165.6 ppm (d, J=6 Hz; Im-2-C); 19F{1H} NMR
(376.5 MHz, CDCl3, 300 K): d=ꢀ167.2 (brs, 8F; C6F5-m-F), ꢀ163.5 (t,
J=20 Hz, 4F; C6F5-p-F), ꢀ160.0 (mc, 2F; Bn-m-F), ꢀ151.4 (t, J=21 Hz,
1F; Bn-p-F), ꢀ141.3 (mc, 2F; Bn-o-F), ꢀ132.9 ppm (brs, 8F; C6F5-o-F);
31P{1H} NMR (202.5 MHz, CDCl3, 295 K): d=23.8 ppm; IR (KBr): n˜ =
3062, 2946, 2884, 1644, 1513, 1463, 1366, 1306, 1272, 1090, 1021, 980, 774,
753, 695, 663, 606, 571, 539, 492 cmꢀ1; MS (ESI+, CH2Cl2): m/z (%)=
breviation BArF refers to the tetrakisACTHNUTRGENUGN[3,5-bis(trifluoromethyl)phenyl]bo-
rate anion, whilst ArF denotes the 3,5-bis(trifluoromethyl)phenyl sub-
stituent in general and ArF any arbitrary fluorinated aryl moiety. The
term dmc refers to a doublet of centered multiplets.
General procedure for the synthesis of zwitterionic complexes
Compound 20a: Absolute NEtiPr2 (153 mL, 0.900 mmol) followed by
ligand 22a (318 mg, 0.300 mmol) in absolute CH2Cl2 (3 mL) were added
dropwise to a solution of [IrACHTUNTGRENUNG(COD)Cl]2 (111 mg, 0.165 mmol) in absolute
CH2Cl2 (5 mL) at room temperature. After the red mixture had been
stirred in a closed vessel for 2 h at 508C, it was cooled to room tempera-
ture, whereupon saturated aqueous NaHCO3 (6 mL) and H2O (2 mL)
were added. The resulting two-phase system was vigorously stirred for
30 min at room temperature, the phases were allowed to separate, and
the aqueous layer was extracted with CH2Cl2 (3ꢄ10 mL). The combined
organic phases were dried over MgSO4, filtered, and concentrated under
reduced pressure. Purification of the crude product by column chroma-
tography under argon (silica gel, 4ꢄ22 cm; CH2Cl2) yielded precatalyst
20a as a red, foamy solid (397 mg, 97%). RF =0.77 (CH2Cl2); [a]2D0 =+
233 (c=0.250 in CHCl3); 1H NMR (500.1 MHz, CDCl3, 295 K): d=1.02
(mc, 1H; CH(N)CH2CHH), 1.15–1.34 (m, 3H; CH(N)CHHCHH), 1.39
(mc, 1H; COD-CHH), 1.54 (mc, 1H; COD-CHH), 1.71–1.89 (m, 3H;
CH(N)CHHCHH), 1.90–2.04 (m, 2H; COD-CHH), 2.08 (t, J=12.8 Hz,
1H; Im-7a’-H), 2.22–2.50 (m, 4H; COD-CH2), 2.58 (brd, J=6.8 Hz, 1H;
CH(N)CHH), 3.07 (brs, 1H; COD-CH), 3.26 (t, J=11.8 Hz, 1H; Im-3a’-
H), 3.84 (brs, 1H; COD-CH), 4.01 (d, J=15.3 Hz, 1H; Bn-CHH), 4.33
(d, J=15.4 Hz, 1H; Bn-CHH), 4.54 (mc, 1H; COD-CH), 5.29 (brs, 1H;
COD-CH), 7.11 (t, J=9.0 Hz, 2H; PPh2-o-H), 7.40–7.73 ppm (m, 12H;
865 (100) [MꢀB
(C6F5)4]+; elemental analysis calcd (%) for
ACHTUNGTRENNUNG
Ar-H);
13C{1H} NMR
(125.8 MHz,
CDCl3,
295 K):
d=24.3
C64H38BF25IrN2P (1543.96): C 49.79, H 2.48, N 1.81; found: C 49.68, H
2.62, N 1.84.
(CH(N)CH2CH2), 25.3 (CH(N)CH2CH2), 25.8 (COD-CH2), 28.2 (COD-
CH2), 29.7 (CH(N)CH2), 34.0 (CH(N)CH2), 34.6 (COD-CH2), 37.2 (d,
J=4 Hz; COD-CH2), 41.4 (Bn-CH2), 61.9 (COD-CH), 64.5 (COD-CH),
69.9 (Im-3a’-CH), 72.0 (Im-7a’-CH), 85.5 (d, J=16 Hz; COD-CH), 94.8
(d, J=9 Hz; COD-CH), 107.7 (t, J=16 Hz; Bn-p-C), 122.1 (d, J=52 Hz;
PPh2-i-C), 123.8 (br; C6F5-i-C and Bn-i-C), 125.0 (d, J=50 Hz; Ar-2’’-C),
128.9 (d, J=53 Hz; PPh2-i-C), 129.0 (d, J=10 Hz; Ar-CH), 129.6 (br; Ar-
CH), 130.4 (br; Ar-CH), 130.9 (Ar-CH), 132.0 (Ar-CH), 132.3 (d, J=
8 Hz; Ar-CH), 132.7 (d, J=13 Hz; Ar-1’’-C), 132.9 (Ar-CH), 133.7 (d, J=
10 Hz; PPh2-o-CH), 136.4 (dmc, J=249 Hz; C6F5-m-C), 138.4 (dmc, J=
250 Hz; C6F5-p-C), 143.7 (dmc, J=248 Hz; Bn-m-C), 148.3 (dmc, J=
241 Hz; C6F5-o-C and Bn-o-C), 165.2 ppm (d, J=5 Hz; Im-2’-C);
19F{1H} NMR (376.5 MHz, CDCl3, 300 K): d=ꢀ167.4 (brs, 2F; C6F5-m-
F), ꢀ167.2 (mc, 2F; C6F5-m-F), ꢀ166.8 (brs, 2F; C6F5-m-F), ꢀ163.3 (t,
J=21 Hz, 1F; C6F5-p-F), ꢀ163.2 (t, J=21 Hz, 2F; C6F5-p-F), ꢀ146.7 (mc,
2F; Bn-m-F), ꢀ133.2 (brs, 2F; ArF-o-F), ꢀ132.8 (brs, 2F; ArF-o-F),
ꢀ132.6 (brs, 2F; ArF-o-F), ꢀ131.8 (brs, 1F; ArF-o-F), ꢀ131.3 ppm (brs,
1F; ArF-o-F); 31P{1H} NMR (202.5 MHz, CDCl3, 295 K): d=24.1 ppm;
11B{1H} NMR (160.5 MHz, CDCl3, 295 K): d=ꢀ16.9 ppm; IR (KBr): n˜ =
3061, 2941, 2883, 1643, 1513, 1462, 1364, 1260, 1090, 978, 894, 770, 695,
664, 539, 464 cmꢀ1; elemental analysis calcd (%) for C58H38BF19IrN2P
(1357.91): C 51.30, H 2.82, N 2.06; found: C 51.41, H 2.93, N 2.21.
General procedure for the preparation of ligands by heteroatom alkyla-
tion
Compound 45a: PHIM 12a (577 mg, 1.50 mmol) was added to a suspen-
sion of KH (66.2 mg, 1.65 mmol) in absolute THF (15 mL) at 08C. After
the mixture had been stirred at room temperature until no further gas
evolution was detected (about 2 h), pentafluorobenzyl bromide (272 mL,
1.80 mmol) was added dropwise to the now yellow solution at 08C. The
resulting yellow suspension was stirred for 2.5 h at 08C and then for 18 h
at room temperature. After the addition of aqueous Na2S2O3 (5%,
20 mL), the mixture was extracted with CH2Cl2 (4ꢄ20 mL). The com-
bined organic phases were dried over MgSO4, filtered, and concentrated
under reduced pressure. Purification of the remaining yellow oil by
column chromatography under argon (silica gel, 4ꢄ19 cm; hexanes/
EtOAc (2:1) + 5 vol% NEt3) yielded ligand 45a as a colorless, foamy
solid (369 mg, 44%). RF =0.31 (hexanes/EtOAc (2:1) + 5 vol% NEt3);
[a]2D0 =ꢀ13.2 (c=0.555 in CHCl3); 1H NMR (400.1 MHz, CDCl3, 300 K):
d=1.13–1.39 (m, 4H; CH(N)CHHCHH), 1.65–1.86 (brm, 3H;
CH(N)CHHCHH), 2.18 (brd, J=10.0 Hz, 1H; CH(N)CHH), 2.68 (brs,
1H; Im-7a-H), 2.88 (brs, 1H; Im-3a-H), 3.93 (brd, J=11.7 Hz, 1H; Bn-
CHH), 4.33 (d, J=14.7 Hz, 1H; Bn-CHH), 7.06 (dd, J=7.1, 4.0 Hz, 1H;
Ar-3’-H), 7.27–7.42 ppm (m, 13H; Ar-H); 13C{1H} NMR (100.6 MHz,
CDCl3, 300 K): d=24.8 (CH(N)CH2CH2), 25.5 (CH(N)CH2CH2), 29.7
(CH(N)CH2), 31.0 (CH(N)CH2), 39.5 (br; Bn-CH2), 71.9 (br; Im-CH),
112.4 (br; Bn-i-C), 128.6–129.0 (several Ar-CH), 129.5 (br; Ar-CH), 132.1
(br; Ar-C), 133.5 (Ar-3’-CH), 134.3 (d, J=20 Hz; PPh2-o-CH), 136.0–
138.7 (several Ar-C), 145.5 (dmc, J=251 Hz; Bn-o-C), 166.6 ppm (br; Im-
2-C); 19F{1H} NMR (376.5 MHz, CDCl3, 300 K): d=ꢀ162.4 (brs, 2F; Bn-
m-F), ꢀ155.2 (brs, 1F; Bn-p-F), ꢀ141.7 ppm (brs, 2F; Bn-o-F);
31P{1H} NMR (162.0 MHz, CDCl3, 300 K): d=ꢀ10.6 ppm; IR (KBr): n˜ =
3056, 2935, 2860, 1962, 1891, 1825, 1654, 1607, 1578, 1505, 1436, 1330,
1303, 1250, 1122, 1015, 963, 938, 745, 696, 668, 543, 507, 418 cmꢀ1; MS
(FAB, NBA): m/z (%)=565 (84) [M+H]+, 487 (12) [MꢀPh]+, 383 (100)
General procedure for the synthesis of cationic precatalysts
Compound 43a: A solution of ligand 45a (113 mg, 0.200 mmol) in abso-
lute CH2Cl2 (2 mL) was added dropwise at room temperature to a solu-
tion of [Ir
After the resulting red solution had been stirred in a closed vessel for 2 h
at 508C, the mixture was cooled to room temperature and Li[B(C6F5)4]
ACHTUNGTRENNUNG(COD)Cl]2 (73.9 mg, 0.110 mmol) in absolute CH2Cl2 (3 mL).
AHCTUNGTRENNUNG
(192 mg, 0.280 mmol) was added. The slightly turbid solution was stirred
for 5 min and then H2O (5 mL) was added. After the mixture had been
vigorously stirred for 30 min at room temperature, the phases were sepa-
rated and the aqueous layer was extracted with CH2Cl2 (3ꢄ10 mL). The
combined organic phases were dried over MgSO4, filtered, and concen-
4142
ꢁ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2011, 17, 4131 – 4144